Corteva, Inc. $CTVA Shares Sold by Capital International Sarl

Capital International Sarl lowered its stake in shares of Corteva, Inc. (NYSE:CTVA) by 36.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 240,574 shares of the company’s stock after selling 136,628 shares during the quarter. Capital International Sarl’s holdings in Corteva were worth $16,126,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in the stock. Drummond Knight Asset Management Pty Ltd acquired a new position in Corteva in the fourth quarter worth $25,713,000. Alberta Investment Management Corp acquired a new position in Corteva in the third quarter worth $5,018,000. Avior Wealth Management LLC boosted its holdings in Corteva by 464.7% in the fourth quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after purchasing an additional 27,075 shares during the period. HighTower Advisors LLC boosted its holdings in Corteva by 8.6% in the third quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock worth $12,352,000 after purchasing an additional 14,436 shares during the period. Finally, Arbejdsmarkedets Tillaegspension acquired a new position in Corteva in the fourth quarter worth $23,679,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $77.06 on Friday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The firm’s 50-day simple moving average is $81.17 and its 200 day simple moving average is $74.94. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market cap of $51.54 billion, a P/E ratio of 45.33, a P/E/G ratio of 2.36 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the previous year, the business earned $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is 42.35%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Oppenheimer lifted their price objective on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Morgan Stanley boosted their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. BNP Paribas Exane boosted their price target on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Finally, Argus boosted their price target on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.